Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra Kennedy

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The American Journal of Psychiatry|May 1, 2014
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational studyOrna Diav-Citrin, Svetlana Shechtman, Esther Tahover, et al.
The American Journal of Psychiatry|April 3, 2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancyAdrienne Einarson, Alessandra Pistelli, Marco DeSantis, et al.
The Australasian Journal of Dermatology|May 2, 2024
Prescription retinoid and contraception use in women in Australia: A population-based studyLaura Gerhardy, Natasha Nassar, Melisa Litchfield, et al.
The Australasian Journal of Dermatology|May 26, 2017
Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis CollaborationMarius Rademaker, Karen Agnew, Megan Andrews, et al.
Case Reports in Medicine|May 19, 2025
Beating the Odds: A Successful Pregnancy in a Patient With ALK-Rearranged Lung Cancer on AlectinibNicholas Yeo, Fiona Johnston, Louise Fay, et al.
The Lancet. Haematology|January 6, 2025
Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancyGeorgia Mills, Antonia Shand, Debra Kennedy, et al.
Blood|December 17, 2009
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosisFabio P S Santos, Hagop M Kantarjian, Nitin Jain, et al.
Leukemia & Lymphoma|July 30, 2023
Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginaseAnthony Jeffrey, Peter Presgrave, Colin A Walsh, et al.
Gut|March 21, 2023
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feedingRobyn Laube, Christian P Selinger, Cynthia H Seow, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The American Journal of Psychiatry|May 1, 2014
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational studyOrna Diav-Citrin, Svetlana Shechtman, Esther Tahover, et al.
The American Journal of Psychiatry|April 3, 2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancyAdrienne Einarson, Alessandra Pistelli, Marco DeSantis, et al.
The Australasian Journal of Dermatology|May 2, 2024
Prescription retinoid and contraception use in women in Australia: A population-based studyLaura Gerhardy, Natasha Nassar, Melisa Litchfield, et al.
The Australasian Journal of Dermatology|May 26, 2017
Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis CollaborationMarius Rademaker, Karen Agnew, Megan Andrews, et al.
Case Reports in Medicine|May 19, 2025
Beating the Odds: A Successful Pregnancy in a Patient With ALK-Rearranged Lung Cancer on AlectinibNicholas Yeo, Fiona Johnston, Louise Fay, et al.
The Lancet. Haematology|January 6, 2025
Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancyGeorgia Mills, Antonia Shand, Debra Kennedy, et al.
Blood|December 17, 2009
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosisFabio P S Santos, Hagop M Kantarjian, Nitin Jain, et al.
Leukemia & Lymphoma|July 30, 2023
Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginaseAnthony Jeffrey, Peter Presgrave, Colin A Walsh, et al.
Gut|March 21, 2023
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feedingRobyn Laube, Christian P Selinger, Cynthia H Seow, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
Pageof 5